Negative glucocorticoid receptor response elements and their role in glucocorticoid action

Current Pharmaceutical Design
A Dostert, T Heinzel

Abstract

The glucocorticoid receptor (GR) belongs to the steroid hormone receptor subclass of nuclear receptors and controls physiological processes through activation and repression of specific target genes. The ligand-activated receptor dimer activates gene expression by binding to specific DNA sequences (glucocorticoid response element, GRE) in the promoter regions of glucocorticoid-regulated genes. In contrast to the regulation of these classical GREs, the repression of negatively regulated target genes is mediated by negative GREs (nGRE), composite GREs or by transrepression. Due to their broad therapeutic spectrum and superior therapeutic effects glucocorticoids (GCs) are the most effective drugs used for the treatment of acute and chronic inflammatory diseases. Unfortunately, long term systemic therapy with GCs is restricted due to their metabolic side effects. It is assumed that transrepression of transcription factors such as AP-1 and NF-kappa B is the main mechanism by which glucocorticoids mediate their anti-inflammatory activity, whereas the side effects of GCs are mainly mediated by GR-DNA-interaction either by activation or by negative regulation of gene expression. While trans-repression has been characterized in detail, ...Continue Reading

Citations

Feb 8, 2007·Journal of Pharmacokinetics and Pharmacodynamics·Anasuya HazraWilliam J Jusko
May 7, 2005·Molecular and Cellular Endocrinology·Christoph GeserickBernard Haendler
Oct 21, 2005·The New England Journal of Medicine·Turk Rhen, John A Cidlowski
Jul 30, 2011·The Journal of Biological Chemistry·Peter J Barnes
Jun 30, 2012·The Journal of Pharmacology and Experimental Therapeutics·Andreas R BaudyEric P Hoffman
Oct 22, 2005·American Journal of Respiratory Cell and Molecular Biology·Yajun ChenMary C Rose
Nov 9, 2007·American Journal of Respiratory Cell and Molecular Biology·Jing-Qing YangMichael Roth
Jul 17, 2012·American Journal of Respiratory Cell and Molecular Biology·Yajun ChenMary C Rose
Jan 10, 2009·Endocrinology·Sam JohnGordon L Hager
Sep 28, 2013·Cancer Immunology, Immunotherapy : CII·Shlomit Kfir-Erenfeld, Eitan Yefenof
Feb 11, 2011·Bioscience, Biotechnology, and Biochemistry·Ken-ichi Takeyama, Shigeaki Kato
Jul 30, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Brian W MaclaughlinHakima Amri
Sep 21, 2010·Cellular and Molecular Life Sciences : CMLS·Jian ZhouChun-Lei Jiang
Sep 8, 2009·Expert Opinion on Drug Metabolism & Toxicology·Etienne Audet-WalshAlan Anderson
Dec 10, 2008·Stress : the International Journal on the Biology of Stress·Thaddeus W W PaceRobert L Spencer
Dec 4, 2008·Stress : the International Journal on the Biology of Stress·Simon C Biddie, Gordon L Hager
Feb 24, 2016·Biochemical Pharmacology·Christine R KeenanAlastair G Stewart
Mar 20, 2012·Cellular Signalling·Torsten GinterOliver H Krämer
Jan 4, 2012·Pharmacology & Therapeutics·Andrew R Clark, Maria G Belvisi
Jun 2, 2009·Lancet·Peter J Barnes, Ian M Adcock
Sep 23, 2008·Trends in Endocrinology and Metabolism : TEM·Katherine L Gross, John A Cidlowski
Oct 5, 2007·Pulmonary Pharmacology & Therapeutics·Mari HämäläinenEeva Moilanen
Jul 17, 2007·Molecular and Cellular Endocrinology·Heike SchäckeKhusru Asadullah
Jun 26, 2007·Molecular and Cellular Endocrinology·Anna Kleiman, Jan P Tuckermann
May 2, 2007·General and Comparative Endocrinology·Nicolas R Bury, Armin Sturm
Feb 13, 2007·Trends in Molecular Medicine·Mark LöwenbergDaniel W Hommes
Apr 11, 2006·British Journal of Pharmacology·Peter J Barnes
Dec 7, 2006·Annals of the New York Academy of Sciences·Ioannis KyrouConstantine Tsigos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here